Key terms

About ENTX

Entera Bio Ltd. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of orally delivered large molecule therapeutics. It s pipeline include PTH, GLP-E, and hGh, The company was founded on September 30, 2009 and is headquartered in Jerusalem, Israel.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest ENTX news

Apr 15 10:45am ET Biotech Alert: Searches spiking for these stocks today Apr 12 11:08am ET Biotech Alert: Searches spiking for these stocks today Apr 08 8:54am ET Entera Bio publishes data on oral PTH peptide tablet for osteoporosis in JBMR Apr 02 6:30am ET Analysts Offer Insights on Healthcare Companies: Genelux Corp. (GNLX), Adicet Bio (ACET) and Entera Bio (ENTX) Mar 20 8:10am ET Entera Bio announces PK data from oral GLP-2 peptide tablet treatment Mar 19 4:55am ET Entera Bio management to meet virtually with Oppenheimer Mar 18 4:55am ET Entera Bio management to meet virtually with Oppenheimer Mar 13 4:08pm ET Entera Bio management to meet virtually with Oppenheimer Mar 12 4:55am ET Entera Bio management to meet with Oppenheimer Mar 08 4:23pm ET Entera Bio Ltd Shares Financial Update for Investor Awareness Mar 08 4:55am ET Entera Bio management to meet with Oppenheimer Mar 05 9:45pm ET Entera Bio management to meet with Oppenheimer Mar 05 9:44pm ET Entera Bio management to meet with Oppenheimer Mar 04 8:40am ET Entera Bio regains compliance with Nasdaq minimum bid price requirement Feb 02 4:19pm ET Entera Bio files to sell 16.5M ordinary shares for holders Jan 19 11:24am ET Biotech Alert: Searches spiking for these stocks today Jan 18 11:32am ET Biotech Alert: Searches spiking for these stocks today

No recent press releases are available for ENTX

ENTX Financials

1-year income & revenue

Key terms

ENTX Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

ENTX Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms